IMMUNE STATUS OF PATIENTS WITH CHRONIC MICROBIAL ECZEMA AND ELEVATED IGG4 LEVELS TO MOLD ALLERGENS
Clinical medicine

IMMUNE STATUS OF PATIENTS WITH CHRONIC MICROBIAL ECZEMA AND ELEVATED IGG4 LEVELS TO MOLD ALLERGENS

Published 2025-08-28

Authors:

I.B. Popova
I.P. Kaidashev
Ya.O. Yemchenko
K.V. Vasylieva
N.Y. Reznichenko
V.I. Kameniev
K.Ye. Ishcheikin

Abstract:
According to the World Allergy Organization, 40 % of the global population has one or more allergic diseases and daily struggles with the fear of potential asthma attacks, complications, or even death from various allergic reactions. A clear dependence of the development of allergic diseases on the degree of air contamination by fungi and their spores has been established. Therefore, the study of specific immune reactions to antigens of mold and yeast-like fungi is extremely relevant. Overall, elevated levels of specific IgG4 were detected in 95.7 % of patients to at least one of the studied allergens. The frequency of elevated specific IgG4 levels to each of the studied mold allergens was as follows: Mucor racemosus – 65.2 %, Candida albicans – 54.3 %, Aspergillus fumigatus – 41.3 %, Alternaria tenuis – 34.8 %, Penicillium notatum – 6.5 %, Cladosporium herbarum– 4.3 %. For the etiological diagnosis of exacerbations in chronic microbial eczema and uncontrolled disease progression, the determination of specific fungal IgE and IgG is informative. This will clarify the nature of sensitization and enable adequate treatment for patients with chronic microbial eczema.
Keywords:
sensitization mold fungi microbial eczema IgG4
References:
  1. Agache I, Bousquet J, Berger U, Bergmann KC, Besancenot JP, Kaidashev I, et al. Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries. Int Arch Allergy Immunol. 2018;176(3-4):181-188. doi: 10.1159/000488391.
  2. Celakovská J, Josef B, Ettler K, Vaneckova J, Ettlerova K. Sensitization to Fungi in Atopic Dermatitis Patients 14 Year and Older - Association with Other Atopic Diseases and Parameters. Indian J Dermatol. 2018 Sep-Oct;63(5):391-398. doi: 10.4103/ijd.IJD_493_17.
  3. Lugović-Mihić L, Meštrović-Štefekov J, Potočnjak I, Cindrić T, Ilić I, et al. Atopic Dermatitis: Disease Features, Therapeutic Options, and a Multidisciplinary Approach. Life (Basel). 2023 Jun 20;13(6):1419. doi: 10.3390/life13061419.
  4. Qin L, Tang LF, Cheng L, Wang HY. The clinical significance of allergen-specific IgG4 in allergic diseases. Front Immunol. 2022 Oct 25;13:1032909. doi: 10.3389/fimmu.2022.1032909.
  5. Sztandera-Tymoczek M, Szuster-Ciesielska A. Fungal Aeroallergens-The Impact of Climate Change. J Fungi (Basel). 2023 May 7;9(5):544. doi: 10.3390/jof9050544.
  6. Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int. J. Mol. Sci. 2021;22:4130. doi: 10.3390/ijms22084130.
  7. Tancredi V, Buononato D, Caccavale S, Di Brizzi EV, Di Caprio R, et al. New Perspectives in the Management of Chronic Hand Eczema: Lessons from Pathogenesis. Int J Mol Sci. 2023 Dec 27;25(1):362. doi: 10.3390/ijms25010362.
  8. Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, et al. European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2717-2744. doi: 10.1111/jdv.16892.
  9. Yaneva M, Darlenski R. The link between atopic dermatitis and asthma- immunological imbalance and beyond. Asthma Res Pract. 2021 Dec 15;7(1):16. doi: 10.1186/s40733-021-00082-0.
  10. Zhdan VM, Tkachenko MV, Babanina MY. Analysis of inflammatory changes of entheses and synovial structures in patients with psoriasis and psoriatic arthritis. World of Medicine and Biology 2023;3(85): 70-75. doi.org/10.26724/2079-8334-2023-3-85-70-75.
Publication:
«World of Medicine and Biology» Vol. 21 No. 93 (2025) , с. 120-124
УДК 616.51:616.9:582.281.21:612.017